A CT-based radiomics model to predict subsequent brain metastasis in patients with ALK-rearranged non-small cell lung cancer undergoing crizotinib treatment.
Yongluo JiangYixing WangSha FuTao ChenYixin ZhouXuanye ZhangChen ChenLi-Na HeWei DuHaifeng LiZuan LinYuanyuan ZhaoYunpeng YangHongyun ZhaoWenfeng FangYan HuangShaodong HongLi ZhangPublished in: Thoracic cancer (2022)
We have developed a CT-based radiomics model to predict subsequent BM in patients with non-brain metastatic NSCLC undergoing crizotinib treatment. Selection of an enriched patient population at high BM risk will facilitate the design of clinical trials or strategies to prevent BM.